A genomic screen identifies TYRO3 as a MITF regulator in melanoma
- 6 October 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 106 (40), 17025-17030
- https://doi.org/10.1073/pnas.0909292106
Abstract
Malignant melanoma is the most aggressive form of cutaneous carcinoma, accounting for 75% of all deaths caused by skin cancers. Microphthalmia-associated transcription factor (MITF) is a master gene regulating melanocyte development and functions as a “lineage addiction” oncogene in malignant melanoma. We have identified the receptor protein tyrosine kinase TYRO3 as an upstream regulator of MITF expression by a genome-wide gain-of-function cDNA screen and show that TYRO3 induces MITF-M expression in a SOX10-dependent manner in melanoma cells. Expression of TYRO3 is significantly elevated in human primary melanoma tissue samples and melanoma cell lines and correlates with MITF-M mRNA levels. TYRO3 overexpression bypasses BRAF(V600E)-induced senescence in primary melanocytes, inducing transformation of non-tumorigenic cell lines. Furthermore, TYRO3 knockdown represses cellular proliferation and colony formation in melanoma cells, and sensitizes them to chemotherapeutic agent-induced apoptosis; TYRO3 knockdown in melanoma cells also inhibits tumorigenesis in vivo. Taken together, these data indicate that TYRO3 may serve as a target for the development of therapeutic agents for melanoma.Keywords
This publication has 59 references indexed in Scilit:
- Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITFPLOS ONE, 2008
- Immunobiology of the TAM receptorsNature Reviews Immunology, 2008
- Growth arrest-specific gene 6 expression in human breast cancerBritish Journal of Cancer, 2008
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7Cell, 2008
- TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human CancerAdvances in Cancer Research, 2008
- Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survivalProceedings of the National Academy of Sciences, 2006
- Complex Variant 15;17 Translocations in Acute Promyelocytic Leukemia: A Case Report and Review of Three-Way TranslocationsCancer Genetics and Cytogenetics, 1999
- Tyro 3 Receptor Tyrosine Kinase and its Ligand, Gas6, Stimulate the Function of OsteoclastsThe International Journal of Cell Cloning, 1998
- Identification of the Product of Growth Arrest-specific Gene 6 as a Common Ligand for Axl, Sky, and Mer Receptor Tyrosine KinasesJournal of Biological Chemistry, 1996
- Autophosphorylation Activity and Association with Src Family Kinase of Sky Receptor Tyrosine KinaseBiochemical and Biophysical Research Communications, 1995